Cosequin and Rimadyl are drugs that are used concurrently to treat hip dysplasia, arthritis and degenerative joint disease (DJD).  While we cannot reverse the course of any of these conditions, we can slow or stop their progression and decrease the associated inflammation and pain.

Cosequin contains glucosamine, chondroitin sulfate and glycosaminoglycans.  These substances promote the health of articular (joint) cartilage and may prevent progression of DJD.  Cosequin is administered twice a day as a dietary supplement and when given in recommended dosages, has no detrimental side effects.  Cosequin is given at the label dosage (by weight of the patient) for four to six weeks.  If a positive response is noted, the dosage may be decreased after the four to six week loading dose period.

Rimadyl is a new non-steroidal anti-inflammatory drug that has an action similar to that of aspirin but, unlike all other non-steroidal anti-inflammatory drugs, Rimadyl does not cause stomach upset or GI ulceration, and Rimadyl may be given with steroidal anti-inflammatory drugs.  In addition, Rimadyl is more effective than aspirin and other over the counter anti-inflammatory products.  Rimadyl is effective at alleviating pain and inflammation in general and is especially effective for alleviating pain and inflammation resulting from DJD and arthritis.  Rimadyl is administered twice per day with dosage based upon the weight of the patient.  Rimadyl is available only as a prescription veterinary drug.

Dogs with hip dysplasia, arthritis or DJD are initially treated with both Cosequin and Rimadyl.  Ideally, the dosage of Cosequin is decreased after four to six weeks and Rimadyl is discontinued or given only on "bad days".  If you have any questions, be sure to call your Veterinarian.